Potential Lawsuit: Allergan Accused of Keeping Generic Restasis Off the Market

Dallas, TX: Allergan could be facing a proposed antitrust class action lawsuit based on allegations made by direct purchases of the pharmaceutical company’s Restasis, a medication for dry eyes. The plaintiffs allege that Allergan blocked low-cost generic versions from entering the market.